Literature DB >> 25154416

14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation.

Ashraf Dar1, David Wu1, Nicholas Lee1, Etsuko Shibata1, Anindya Dutta2.   

Abstract

Cdt2 is the substrate recognition adaptor of CRL4(Cdt2) E3 ubiquitin ligase complex and plays a pivotal role in the cell cycle by mediating the proteasomal degradation of Cdt1 (DNA replication licensing factor), p21 (cyclin-dependent kinase [CDK] inhibitor), and Set8 (histone methyltransferase) in S phase. Cdt2 itself is attenuated by SCF(FbxO11)-mediated proteasomal degradation. Here, we report that 14-3-3 adaptor proteins interact with Cdt2 phosphorylated at threonine 464 (T464) and shield it from polyubiquitination and consequent proteasomal degradation. Depletion of 14-3-3 proteins promotes the interaction of FbxO11 with Cdt2. Overexpressing 14-3-3 proteins shields Cdt2 that has a phospho-mimicking mutation (T464D [change of T to D at position 464]) but not Cdt2(T464A) from ubiquitination. Furthermore, the delay of the cell cycle in the G2/M phase and decrease in cell proliferation seen upon depletion of 14-3-3γ is partly due to the accumulation of the CRL4(Cdt2) substrate, Set8 methyltransferase. Therefore, the stabilization of Cdt2 is an important function of 14-3-3 proteins in cell cycle progression.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25154416      PMCID: PMC4386460          DOI: 10.1128/MCB.00838-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors.

Authors:  Elisabeth Simboeck; Anna Sawicka; Gordin Zupkovitz; Silvia Senese; Stefan Winter; Franck Dequiedt; Egon Ogris; Luciano Di Croce; Susanna Chiocca; Christian Seiser
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

Review 2.  Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Nat Rev Mol Cell Biol       Date:  2013-09       Impact factor: 94.444

3.  PIP-box-mediated degradation prohibits re-accumulation of Cdc6 during S phase.

Authors:  Linda Clijsters; Rob Wolthuis
Journal:  J Cell Sci       Date:  2014-01-16       Impact factor: 5.285

4.  NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells.

Authors:  Jie Jessie Lin; Michael A Milhollen; Peter G Smith; Usha Narayanan; Anindya Dutta
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

5.  L2dtl is essential for cell survival and nuclear division in early mouse embryonic development.

Authors:  Chao-Lien Liu; I-Shing Yu; Hung-Wei Pan; Shu-Wha Lin; Hey-Chi Hsu
Journal:  J Biol Chem       Date:  2006-11-15       Impact factor: 5.157

6.  Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma.

Authors:  Hung-Wei Pan; Han-Yi E Chou; Shu-Hsiang Liu; Shian-Yang Peng; Chao-Lien Liu; Hey-Chi Hsu
Journal:  Cell Cycle       Date:  2006-11-15       Impact factor: 4.534

Review 7.  Building and remodelling Cullin-RING E3 ubiquitin ligases.

Authors:  John R Lydeard; Brenda A Schulman; J Wade Harper
Journal:  EMBO Rep       Date:  2013-11-15       Impact factor: 8.807

8.  Cdt1 and Cdc6 are destabilized by rereplication-induced DNA damage.

Authors:  Jonathan R Hall; Hyun O Lee; Brandon D Bunker; Elizabeth S Dorn; Greg C Rogers; Robert J Duronio; Jeanette Gowen Cook
Journal:  J Biol Chem       Date:  2008-07-10       Impact factor: 5.157

9.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

10.  Nascent chromatin capture proteomics determines chromatin dynamics during DNA replication and identifies unknown fork components.

Authors:  Constance Alabert; Jimi-Carlo Bukowski-Wills; Sung-Bau Lee; Georg Kustatscher; Kyosuke Nakamura; Flavia de Lima Alves; Patrice Menard; Jakob Mejlvang; Juri Rappsilber; Anja Groth
Journal:  Nat Cell Biol       Date:  2014-02-23       Impact factor: 28.824

View more
  15 in total

1.  Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor.

Authors:  Michael Peled; Anna S Tocheva; Sabina Sandigursky; Shruti Nayak; Elliot A Philips; Kim E Nichols; Marianne Strazza; Inbar Azoulay-Alfaguter; Manor Askenazi; Benjamin G Neel; Adam J Pelzek; Beatrix Ueberheide; Adam Mor
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-27       Impact factor: 11.205

2.  p70S6K1 (S6K1)-mediated Phosphorylation Regulates Phosphatidylinositol 4-Phosphate 5-Kinase Type I γ Degradation and Cell Invasion.

Authors:  Naser Jafari; Qiaodan Zheng; Liqing Li; Wei Li; Lei Qi; Jianyong Xiao; Tianyan Gao; Cai Huang
Journal:  J Biol Chem       Date:  2016-10-25       Impact factor: 5.157

3.  Regulation of neuronal morphogenesis by 14-3-3epsilon (Ywhae) via the microtubule binding protein, doublecortin.

Authors:  Brett Cornell; Tomoka Wachi; Vladimir Zhukarev; Kazuhito Toyo-Oka
Journal:  Hum Mol Genet       Date:  2016-10-15       Impact factor: 6.150

4.  CDK1-dependent inhibition of the E3 ubiquitin ligase CRL4CDT2 ensures robust transition from S Phase to Mitosis.

Authors:  Lindsay F Rizzardi; Kate E Coleman; Dileep Varma; Jacob P Matson; Seeun Oh; Jeanette Gowen Cook
Journal:  J Biol Chem       Date:  2014-11-19       Impact factor: 5.157

5.  The Deubiquitinase USP46 Is Essential for Proliferation and Tumor Growth of HPV-Transformed Cancers.

Authors:  Shashi Kiran; Ashraf Dar; Samarendra K Singh; Kyung Yong Lee; Anindya Dutta
Journal:  Mol Cell       Date:  2018-11-08       Impact factor: 17.970

6.  Transcriptome Analysis of Near-Isogenic Lines Provides Novel Insights into Genes Associated with Seed Low-Temperature Germination Ability in Maize (Zea mays L.).

Authors:  Xuhui Li; Hairui Hu; Xinmin Hu; Guihua Wang; Xuemei Du; Li Li; Feng Wang; Junjie Fu; Guoying Wang; Jianhua Wang; Riliang Gu
Journal:  Plants (Basel)       Date:  2022-03-25

7.  FBXO11-mediated proteolysis of BAHD1 relieves PRC2-dependent transcriptional repression in erythropoiesis.

Authors:  Peng Xu; Daniel C Scott; Beisi Xu; Yu Yao; Ruopeng Feng; Li Cheng; Kalin Mayberry; Yong-Dong Wang; Wenjian Bi; Lance E Palmer; Moeko T King; Hong Wang; Yuxin Li; Yiping Fan; Arno F Alpi; Chunliang Li; Junmin Peng; James Papizan; Shondra M Pruett-Miller; Ria Spallek; Florian Bassermann; Yong Cheng; Brenda A Schulman; Mitchell J Weiss
Journal:  Blood       Date:  2021-01-14       Impact factor: 25.476

Review 8.  The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod.

Authors:  Sathya Narayanan Patmanathan; Lee Fah Yap; Paul G Murray; Ian C Paterson
Journal:  J Cell Mol Med       Date:  2015-07-14       Impact factor: 5.310

Review 9.  Regulation of Unperturbed DNA Replication by Ubiquitylation.

Authors:  Sara Priego Moreno; Agnieszka Gambus
Journal:  Genes (Basel)       Date:  2015-06-25       Impact factor: 4.096

10.  Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome.

Authors:  Soham Gupta; Päivi Ylä-Anttila; Simone Callegari; Ming-Han Tsai; Henri-Jacques Delecluse; Maria G Masucci
Journal:  PLoS Pathog       Date:  2018-01-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.